Now exists a scientific proof of increased lymphatic pumping using octreotide: what is its actual role in the chylothorax healing process?
European Journal of Cardio-Thoracic Surgery · 2024
DOI: 10.1093/ejcts/ezad416 ↗Kurz gefasst
Editorial in der Zeitschrift European Journal of Cardio-Thoracic Surgery, 2024. Verfasst von Françoise Le Pimpec-Barthes und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, European Hospital Georges Pompidou, Paris, France. Hauptthemen laut MEDLINE: Chylothorax, Lymphatic Vessels. Die Arbeit nennt 8 Literaturangaben.
Abstract (Originalsprache)
The lymphatic system is essential for life by carrying protein and fatty compounds to the blood circulation. It plays a key role in the homeostasis of all body's tissues. Despite already being identified in the 17th century, this complex network composed of contractile and valvular vessels [1] has remained relatively unknown to clinicians. Yet, it is implicated in the spread of infections and cancers, exceptional situations such as chylothorax or chyloperitoneum and in rare primary or secondary lymphatic diseases (lymphedema, etc.). Chylothorax, regardless of its cause, often presents a significant therapeutic challenge. In certain situations, this event can be life-threatening for patients. The 2 mechanisms leading to chylothorax are either a direct trauma of lymphatic vessel or its rupture from increased pressure due to obstruction. If postoperative chylothorax occurs in a patient without underlying lymphatic disease, it is often easy to treat. Indeed, the lymphatic vessels composed of contractile and valvular lymphatic pacemaker also named ‘lymphangion’ enable rapid healing of small-caliber vessels [2]. Conversely, managing ‘spontaneous’ chylothorax associated with primary or secondary lymphatic disease is a real challenge. The inexhaustible loss of chyle combined with a fat-free diet can lead to the patient's death due to cachexia. Sometimes, both mechanisms are intertwined. For instance, a patient undergoing mediastinal or lung surgery may have an unrecognized lymphatic condition, leading to postoperative chyle leakage. It is the result of valvular incontinence of lymphatic vessels, allowing chyle to reflux into the pleural cavity. The non-closure of lymphatic vessels during lymph node dissection explains this chylous leakage. It can be challenging to stop it because the reflux originates directly from collaterals connected to the thoracic duct. A large retrospective series of cancer excisions identified predictive factors for chylothorax: lobectomy, surgery on the right side, tumour involvement of mediastinal nodes and robot-assisted surgical procedures [3].
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Thoracic Surgery, European Hospital Georges Pompidou, Paris, France.
ORCID-Profile: Françoise Le Pimpec-Barthes
Zitieren
APA
Le Pimpec-Barthes, F., Rendina Iaffaldano, A. G., Masmoudi, H., & Al-Zreibi, C. (2024). Now exists a scientific proof of increased lymphatic pumping using octreotide: what is its actual role in the chylothorax healing process?. European Journal of Cardio-Thoracic Surgery. https://doi.org/10.1093/ejcts/ezad416
Vancouver
Le Pimpec-Barthes F, Rendina Iaffaldano AG, Masmoudi H, Al-Zreibi C. Now exists a scientific proof of increased lymphatic pumping using octreotide: what is its actual role in the chylothorax healing process?. European Journal of Cardio-Thoracic Surgery. 2024. doi:10.1093/ejcts/ezad416
BibTeX
@article{LePimpecBarthes2024,
author = {Le Pimpec-Barthes, Françoise and Rendina Iaffaldano, Amedeo Giuseppe and Masmoudi, Hicham and Al-Zreibi, Charles},
title = {Now exists a scientific proof of increased lymphatic pumping using octreotide: what is its actual role in the chylothorax healing process?},
journal = {European Journal of Cardio-Thoracic Surgery},
year = {2024},
doi = {10.1093/ejcts/ezad416}
}
EUVIMED